MS may increase the risk of Alzheimer's disease, possibly due to changes in the activity of immune T-cells, a new genetic ...

Columnist Desiree Lama describes how her pill box became essential as her life with multiple sclerosis meant more and more ...

Fenebrutinib significantly reduced new lesions with active inflammation in people with relapsing MS in a Phase 2 trial.

Columnist Ahna Crum, who's a practitioner in functional medicine, questioned herself when she had an unexpected MS relapse.

A mouse study showed a link between an infection with herpes simplex virus type 1 (HSV-1), the cause of cold sores, and MS.

An international Phase 2 trial will test BMS-986368 as a potentially new oral therapy for managing multiple sclerosis-related ...

Regular exercise that follows established guidelines for physical activity in MS lead to clinically meaningful improvements ...

A person's total number of visits to multiple sclerosis clinics is not associated with a lower risk of death, a study on ...

Fumarate therapies are equally effective among Black, Hispanic, Asian, and white people with relapsing forms of MS, a real-world study shows.

A six-week music-based intervention may reduce psychosocial fatigue and heat pain sensitivity in people with multiple ...

Vibration therapy eases fatigue and improves motor and cognitive outcomes in MS, outperforming standard physical exercise ...

Mesenchymal stem cell therapy lessens disability and brain lesions in MS patients, according to a review of published studies ...